These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1851455)

  • 1. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide.
    Nilsson C; Fahrenkrug J; Lindvall-Axelsson M; Owman C
    Brain Res; 1991 Mar; 542(2):241-7. PubMed ID: 1851455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
    Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
    Guijarro LG; Rodriguez-Pena MS; Prieto JC
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S; Said SI
    J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M; Carlquist M; Maletti M; Marie JC
    FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
    Couvineau A; Gammeltoft S; Laburthe M
    J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
    J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S; Veliçelebi G
    Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G
    Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
    Nguyen TT; Krco CJ; Gores A; Go VL
    Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits].
    Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L
    Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
    Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
    Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.